IGF2BP3 and breast carcinoma: The results of our study suggest that IGF2BP3 expression is associated with specific clinicopathological characteristics of breast cancer, and the positivity rate of IGF2BP3 is significantly higher in breast cancer tissues compared to normal breast tissues highlights the potential role of IGF2BP3 in the development of breast cancer.